Jamitzky et al., on the other hand, found that inhibition of insulin-like growth factor-1 receptor (IGF-1R) significantly promoted the proliferation of human NK cells and could be used to combat Ewing sarcoma (68). This evidence concerns the gene IGF1R and Ewing sarcoma.